HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allam Ramanjaneyulu Selected Research

IRS 954

6/2007Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allam Ramanjaneyulu Research Topics

Disease

1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2009
1Necrosis
07/2009
1Neoplasms (Cancer)
07/2009
1Glomerulonephritis
08/2007
1Immune Complex Diseases (Immune Complex Disease)
08/2007
1Lung Injury
06/2007
1Lupus Nephritis
06/2007

Drug/Important Bio-Agent (IBA)

1Cisplatin (Platino)FDA LinkGeneric
07/2009
1Pharmaceutical PreparationsIBA
07/2009
1Proteins (Proteins, Gene)FDA Link
07/2009
1HMGB ProteinsIBA
07/2009
1CytokinesIBA
07/2009
1Interleukin-6 (Interleukin 6)IBA
08/2007
1Viral RNAIBA
08/2007
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2007
1Imiquimod (Aldara)FDA LinkGeneric
08/2007
1Antigen-Antibody Complex (Immune Complex)IBA
08/2007
1AutoantibodiesIBA
08/2007
1RNA (Ribonucleic Acid)IBA
08/2007
1Immunoglobulin G (IgG)IBA
06/2007
1Interleukin-12 Subunit p40IBA
06/2007
1IRS 954IBA
06/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
07/2009
1Ligation
08/2007
1Intraperitoneal Injections
06/2007